I-Symmetrel njenge-Treatment ye-MS Ukukhathala

Ingabe ngempela kuyindlela ephephile futhi ephumelelayo?

I-Symmetrel (i-amantadine hydrochloride) iyisidakamizwa esilashwa yi-anti-virus esetshenziselwa ukwelapha isifo sika-Parkinson kodwa ngokuvamile iyalulwe ngaphandle-ilebula ukuphatha ukukhathala kubantu abane- multiple sclerosis (MS) . Kwakusetshenziswe futhi ngaphambili ukuphatha umkhuhlane kodwa usuqedile ngenxa yokuphikiswa kwama-amantadine.

Imiphumela yokulwa nokukhathala yaqala ukutholwa lapho abantu abane-MS bephathwa nge-Asian flu futhi bathola ukuthi amazinga azo amandla aphuthumayo futhi athuthuka kakhulu.

Nakuba i-Symmetrel namuhla isetshenziselwa ukuphatha ukukhathala okuhlobene ne-MS , ayikakamukelwa ngalokhu ukusetshenziswa yi-US Food and Drug Administration.

Indlela Symmetrel isebenza ngayo

I-Symmetrel yenza ngokuqondile ohlelweni lwezinzwa zomphakathi futhi kusiza ukugqugquzela ukukhiqizwa kwe-dopamine, i-neurotransmitting chemicals efana ne-adrenaline. I-Dopamine ithinta ingxenye yengqondo eyaziwa ngokuthi i- basal ganglia esiza ukulawula ukunyakaza, ukuphendula ngokomzwelo, nokukwazi ukujabulela injabulo nobuhlungu.

Ngenkathi i-Symmetrel ibonakala inika inzuzo encane kubantu abaphila nesifo sikaParkinson, lezo ziphutha ziye zahunyushwa ngokukhululeka okuncane kuya kokulinganisela kubantu abanokukhathala okuhlobene ne-MS. Indlela yokusebenza ayisaqondakali ngokuphelele, kodwa izinzuzo ezibonwayo zifana nokuthi i-Symmetrel ibhekwa ngabaningi ukuba ibe yindlela yokuqala yokuphatha lesi simo esidabukisayo nesivame ukulimaza.

Ukusebenza kwe-Symmetrel

Ucwaningo olwenziwe ngo-2014 luhlolisise ukuphumelela kwezidakamizwa ezisekelwe ku-Modified Fatigue Impact Scale (MFIS) okulinganisa ukukhathala ngesilinganiso sika-0 kuya ku-84. Ngemva kokusebenzisa inyanga eyodwa, i-Symmetrel yayihlotshaniswa nokunciphisa amaphesenti angama-34 ebuqini bokukhathala kubantu abane-MS.

Nakuba kuqakathekile, uma kuqhathaniswa nezinye ukwelashwa ezifana ne-aspirin noma i-acetyl-L-carnitine (isandiso sokudla esidumile), i-Symmetrel ayibonakalwanga ukuthi iyasebenza nakakhulu noma engasebenzi.

Isiphakamiso sokulinganisa

Ukuphatha ukukhathala kuhlobene ne-MS, isilinganiso esivamile singama-100 kuya ku-200 mg nsuku zonke, sithathwe masinyane ngosuku ukuze singaphazamisi ubuthongo. Kufika kokubili ukubunjwa kwamapilisi e-orange triangular futhi njengesiraphu esithande izithelo.

Imiphumela Yokwelashwa Side Side

Imiphumela emibi ye-Symmetrel ngokuvamile ibhekwe njengengane encane. Izimpawu ezivame kakhulu ezihilela ukujula nomlomo owomile. Amanani angaphezu kuka-300 milligrams ngezinye izikhathi angabangela i-liveo reticularis, isimo sesikhumba esibonakala ngamabhuloki aphuzi emilenzeni.

Ezinye imiphumela emibi ye-Symmetrel, ngenkathi engavamile, ihlanganisa:

Eziningi zalezi zimpawu , ezifana nokulala nokulala komzimba , zivame ukuhlotshaniswa ne-multiple sclerosis. Ngakho-ke, kubalulekile ukuqapha noma yikuphi ukuwohloka noma ukutholakala kwezimpawu lapho ukwelashwa kuqalwa ukuhlola kangcono ukuthi imbangela ihlobene nokusebenzisa izidakamizwa noma ukuphindaphinda kwe-MS .

Ukucatshangelwa nokuphambana

I-Symmetrel kufanele isetshenziswe ngokucophelela kubantu abane-disorder disorder, inkinga yenhliziyo, ukungasebenzi kwezinso, noma ukucindezeleka komtholampilo njengoba ukusetshenziswa kwayo kungase kukhulise imbangela eyimbangela noma kubangele umcimbi omubi.

Abantu abatholwa ukuthi bane-schizophrenia noma ezinye izifo zengqondo akufanele zibekwe njengoba i-Symmetrel ingadala kakhulu izimpawu zengqondo.

Ngenxa yokuntuleka kocwaningo, i-Symmetrel ayinconywa ngesikhathi sokukhulelwa njengoba kungaziwa ukuthi umuthi ungabangela ingozi kumntwana. Kumelwe futhi kugwenywe ngesikhathi sokuncelisa ibele kanye nabesifazane abahlela ukukhulelwa.

> Imithombo:

> Generali, J. noCada, D. "Amantadine: Ukukhathala Okuxubile Kwama-Multiple." Hosp Pharm . 2014; 49 (8): 710-712.

> Ukuphathwa Kwezokudla Nezidakamizwa zase-US. " Symmetrel (Amantadine Hydrochloride) Isiraphu namathebulethi." I-Silver Springs, eMadland; ibuyekeziwe ngoJanuwari 2009.